In addition, CSF1R targeting small molecules, including ARRY-382, PLX7486, BLZ945, and JNJ-40346527, which target the intracellular tyrosine kinase of CSF1R, are in completed or ongoing studies in solid tumors and classical Hodgkin lymphoma (96). Here, CSF1R is linked to classic Hodgkin lymphoma.